Analyze Diet
Antioxidants (Basel, Switzerland)2020; 9(5); 444; doi: 10.3390/antiox9050444

Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses.

Abstract: The study aims to assess the impact of age, pituitary pars intermedia dysfunction (PPID) and insulin dysregulation (ID) in horses on selected oxidative stress markers. The study includes 32 horses, divided into three groups: "young" adult group (aged 8-16 years old) "geriatric" group (aged 18-24 years old) and the "PPID" group (aged 15-31 years old). The PPID group was further divided into two subgroups: PPID ID+ and PPID ID- based on presence or absence of ID. We measured serum antioxidant stress markers in all horses: total oxidant status (TOS), total antioxidant capacity (TAC), ceruloplasmin (CER), lipofuscin (LPS), malondialdehyde (MDA) and thiols concentrations (containing sulfhydryl group -SH) as well as enzymatic systems: total superoxide dismutase (SOD), cytoplasmic SOD (CuZnSOD), mitochondrial SOD activity (MnSOD). Total serum thiols were significantly lower in the geriatric group and in the PPID group compared to the young group. The MnSOD concentration was higher in the PPID ID+ group compared to the PPID ID-. LPS and MDA concentrations were lower in the PPID ID+ group compared to the PPID ID- group. In the selected study groups of horses, older age, the presence of PPID and ID in the case of PPID had no effect on the studied oxidative stress markers.
Publication Date: 2020-05-21 PubMed ID: 32455574PubMed Central: PMC7278619DOI: 10.3390/antiox9050444Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates how age, pituitary dysfunctions, and insulin problems affect certain antioxidant markers in horses. It discovered lower levels of a particular type of antioxidant in older horses, and variations in antioxidant levels in horses with pituitary dysfunction based on their insulin health, but overall found no significant effect of these factors on the measured oxidative stress markers.

Research Overview

  • “Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses” is a study assessing the impact of aging, pituitary pars intermedia dysfunction (PPID), and insulin dysregulation (ID) on oxidative stress markers in horses.
  • The research involved 32 horses divided into groups based on aging and medical conditions: a “young” adult group, a “geriatric” group, and a group of horses with PPID. The PPID group was further divided based on presence or absence of insulin dysregulation (ID+ and ID-).

Marker Assessment and Findings

  • All the participating horses underwent measurement of serum antioxidant stress markers including total oxidant status (TOS), total antioxidant capacity (TAC), ceruloplasmin (CER), lipofuscin (LPS), malondialdehyde (MDA), and sulfhydryl group-bearing thiols concentrations as well as enzymatic systems like total superoxide dismutase (SOD), cytoplasmic SOD (CuZnSOD), and mitochondrial SOD activity (MnSOD).
  • The total serum thiols levels were notably lower in both the geriatric group and the PPID group compared to the younger horse group.
  • Interestingly, the concentrations of MnSOD were higher in the PPID group with insulin dysregulation compared to the subgroup without insulin dysregulation. Similarly, LPS and MDA concentrations were lower in the ID+ subgroup.

Conclusion

  • The research concluded older age, the presence of PPID, and insulin dysregulation in horses with PPID did not significantly affect the oxidative stress markers studied.
  • This discovery could be beneficial for veterinary medicine, giving insights on how aging and certain dysfunctions impact oxidative stress in horses.

Cite This Article

APA
Żak A, Siwińska N, Chełmecka E, Bażanów B, Romuk E, Adams A, Niedźwiedź A, Stygar D. (2020). Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses. Antioxidants (Basel), 9(5), 444. https://doi.org/10.3390/antiox9050444

Publication

ISSN: 2076-3921
NlmUniqueID: 101668981
Country: Switzerland
Language: English
Volume: 9
Issue: 5
PII: 444

Researcher Affiliations

Żak, Agnieszka
  • Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
  • Department of Internal Diseases with Clinic for Horses, Dogs and Cats, Wroclaw University of Environmental and Life Sciences, 50-366 Wroclaw, Poland.
Siwińska, Natalia
  • Department of Internal Diseases with Clinic for Horses, Dogs and Cats, Wroclaw University of Environmental and Life Sciences, 50-366 Wroclaw, Poland.
Chełmecka, Elżbieta
  • Department of Statistics, Department of Instrumental Analysis, Faculty of Pharmaceutical Sciences in Sosnowiec Medical University of Silesia, 40-055 Katowice, Poland.
Bażanów, Barbara
  • Department of Pathology, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Romuk, Ewa
  • Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.
Adams, Amanda
  • Department of Veterinary Science, MH Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA.
Niedźwiedź, Artur
  • Department of Internal Diseases with Clinic for Horses, Dogs and Cats, Wroclaw University of Environmental and Life Sciences, 50-366 Wroclaw, Poland.
Stygar, Dominika
  • Department of Physiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 52 references
  1. McFarlane D, Cribb AE. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.. Am J Vet Res 2005 Dec;66(12):2065-72.
    doi: 10.2460/ajvr.2005.66.2065pubmed: 16379648google scholar: lookup
  2. McFarlane D, Dybdal N, Donaldson MT, Miller L, Cribb AE. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction.. J Neuroendocrinol 2005 Feb;17(2):73-80.
  3. Horohov DW, Adams AA, Chambers TM. Immunosenescence of the equine immune system.. J Comp Pathol 2010 Jan;142 Suppl 1:S78-84.
    doi: 10.1016/j.jcpa.2009.10.007pubmed: 19897209google scholar: lookup
  4. Pamplona R, Portero-Otín M, Riba D, Ruiz C, Prat J, Bellmunt MJ, Barja G. Mitochondrial membrane peroxidizability index is inversely related to maximum life span in mammals.. J Lipid Res 1998 Oct;39(10):1989-94.
    pubmed: 9788245
  5. Adiga U, Adiga S. Total Antioxidant Activity in Old age. Biomed. Res. 2008;19:185–186.
  6. Czech A, Kiesz M, Ognik K, Różański P. Influence of the manner of use, age and sex on the biochemical and antioxidant blood parameters of Malopolski horses. Med. Weter. 2016;72:652–655.
    doi: 10.21521/mw.5567google scholar: lookup
  7. Górecka R, Sitarska E, Kluciński W. Antioxidant parameters of horses according to age, sex, breed and environment.. Pol J Vet Sci 2002;5(4):209-16.
    pubmed: 12512552
  8. Firląg M, Kamaszewski M, Gaca K, Bałasińska B. Age-related changes in the central nervous system in selected domestic mammals and primates.. Postepy Hig Med Dosw (Online) 2013 Apr 11;67:269-75.
    doi: 10.5604/17322693.1044490pubmed: 23619226google scholar: lookup
  9. McFarlane D, Donaldson M.T, Saleh T.M, Cribb A.E. The role of dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction (equine Cushing’s disease). Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners; New Orleans, LA, USA. 21–25 November 2003; pp. 233–237.
  10. McFarlane D. Equine pituitary pars intermedia dysfunction.. Vet Clin North Am Equine Pract 2011 Apr;27(1):93-113.
    doi: 10.1016/j.cveq.2010.12.007pubmed: 21392656google scholar: lookup
  11. Keen JA, McLaren M, Chandler KJ, McGorum BC. Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease.. Equine Vet J 2004 Apr;36(3):226-9.
    doi: 10.2746/0425164044877215pubmed: 15147129google scholar: lookup
  12. Equine Endocrinology Group, Frank N, Andrews F, Durham A, Kritchevsky J, McFarlane D, Schott H. Recommendations for the Diagnosis and Treatment of Pituitary Pars Intermedia Dysfunction (PPID). 2015.
  13. McFarlane D, Donaldson MT, McDonnell SM, Cribb AE. Effects of season and sample handling on measurement of plasma alpha-melanocyte-stimulating hormone concentrations in horses and ponies.. Am J Vet Res 2004 Nov;65(11):1463-8.
    pubmed: 15566081doi: 10.2460/ajvr.2004.65.1463google scholar: lookup
  14. Zak A, Siwinska N, Elzinga S, Barker VD, Stefaniak T, Schanbacher BJ, Place NJ, Niedzwiedz A, Adams AA. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.. Domest Anim Endocrinol 2020 Jul;72:106476.
  15. Zak A, Siwinska N, Elzinga S, Barker VD, Stefaniak T, Schanbacher BJ, Place NJ, Niedzwiedz A, Adams AA. Effects of equine metabolic syndrome on inflammation and acute-phase markers in horses.. Domest Anim Endocrinol 2020 Jul;72:106448.
  16. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent.. J Biol Chem 1951 Nov;193(1):265-75.
    pubmed: 14907713
  17. Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity.. Anal Biochem 1984 Nov 1;142(2):290-6.
    doi: 10.1016/0003-2697(84)90467-6pubmed: 6099057google scholar: lookup
  18. Tsuchida M, Miura T, Mizutani K, Aibara K. Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation.. Biochim Biophys Acta 1985 Apr 25;834(2):196-204.
    pubmed: 3995061
  19. Richterich R. Clinical Chemistry. PZWL; Warsaw, Poland: 1971. (In Polish).
  20. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.. Clin Biochem 2004 Apr;37(4):277-85.
  21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.. Anal Biochem 1979 Jun;95(2):351-8.
    doi: 10.1016/0003-2697(79)90738-3pubmed: 36810google scholar: lookup
  22. Koster JF, Biemond P, Swaak AJ. Intracellular and extracellular sulphydryl levels in rheumatoid arthritis.. Ann Rheum Dis 1986 Jan;45(1):44-6.
    doi: 10.1136/ard.45.1.44pmc: PMC1001813pubmed: 3954457google scholar: lookup
  23. McGorum BC, Wilson R, Pirie RS, Mayhew IG, Kaur H, Aruoma OI. Systemic concentrations of antioxidants and biomarkers of macromolecular oxidative damage in horses with grass sickness.. Equine Vet J 2003 Mar;35(2):121-6.
    doi: 10.2746/042516403776114225pubmed: 12638786google scholar: lookup
  24. Niedzwiedz A, Jaworski Z. Oxidant-antioxidant status in the blood of horses with symptomatic recurrent airway obstruction (RAO).. J Vet Intern Med 2014 Nov-Dec;28(6):1845-52.
    doi: 10.1111/jvim.12452pmc: PMC4895620pubmed: 25231643google scholar: lookup
  25. Kirschvink N, Smith N, Fiévez L, Bougnet V, Art T, Degand G, Marlin D, Roberts C, Génicot B, Lindsey P, Lekeux P. Effect of chronic airway inflammation and exercise on pulmonary and systemic antioxidant status of healthy and heaves-affected horses.. Equine Vet J 2002 Sep;34(6):563-71.
    doi: 10.2746/042516402776180223pubmed: 12357995google scholar: lookup
  26. McGorum BC, Fry SC, Wallace G, Coenen K, Robb J, Williamson G, Aruoma OI. Properties of herbage in relation to equine dysautonomia: biochemical composition and antioxidant and prooxidant actions.. J Agric Food Chem 2000 Jun;48(6):2346-52.
    doi: 10.1021/jf991101npubmed: 10888548google scholar: lookup
  27. McGorum BC, Mayhew IG, Amory H, Deprez P, Gillies L, Green K, Mair TS, Nollet H, Wijnberg ID, Hahn CN. Horses on pasture may be affected by equine motor neuron disease.. Equine Vet J 2006 Jan;38(1):47-51.
    doi: 10.2746/042516406775374207pubmed: 16411586google scholar: lookup
  28. Valentine BA, Hintz HF, Freels KM, Reynolds AJ, Thompson KN. Dietary control of exertional rhabdomyolysis in horses.. J Am Vet Med Assoc 1998 May 15;212(10):1588-93.
    pubmed: 9604030
  29. Dimock AN, Siciliano PD, McIlwraith CW. Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint.. Equine Vet J 2000 Sep;32(5):439-43.
    doi: 10.2746/042516400777591129pubmed: 11037267google scholar: lookup
  30. Williams CA, Gordon ME, Betros CL, McKeever KH. Apoptosis and antioxidant status are influenced by age and exercise training in horses.. J Anim Sci 2008 Mar;86(3):576-83.
    doi: 10.2527/jas.2007-0585pubmed: 18156356google scholar: lookup
  31. Smarch D.N., Williams C.A. Oxidative Stress and Antioxidant Status in Standardbreds: Effect of Age and Acute Phase Exercise Before and After Training. J. Equine Vet. Sci. 2016;47:92–106.
  32. De Moffarts B, Kirschvink N, Van Erck E, Art T, Pincemail J, Lekeux P. Assessment of the oxidant–antioxidant blood balance in a field exercise test in Standardbredand eventing horses. Equine Comp. Exerc. Physiol. 2005;2:253–261.
    doi: 10.1079/ECP200567google scholar: lookup
  33. Niedźwiedź A, Kubiak K, Nicpoń J. Plasma total antioxidant status in horses after 8-hours of road transportation.. Acta Vet Scand 2013 Aug 14;55(1):58.
    doi: 10.1186/1751-0147-55-58pmc: PMC3751896pubmed: 23945316google scholar: lookup
  34. Soffler C. Oxidative stress.. Vet Clin North Am Equine Pract 2007 May;23(1):135-57.
    doi: 10.1016/j.cveq.2006.11.004pubmed: 17379114google scholar: lookup
  35. Kirschvink N, de Moffarts B, Farnir F, Pincemail J, Lekeux P. Investigation of blood oxidant/antioxidant markers in healthy competition horses of different breeds.. Equine Vet J Suppl 2006 Aug;(36):239-44.
  36. Mochizuki M, Minowa F, Ishimoto C, Gin A, Ishioka K, Okubo K. The effect of aging on biochemical markers in equine serum. J. Equine Vet. Sci. 2016;42:1–6.
  37. Suresh D, Kumaran S, Annam V, Veena H. Age related changes in malondialdehyde: Total antioxidant capacity ratio—A novel marker of oxidative stress. Int. J. Pharma Bio Sci. 2010;1:1–6.
  38. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, Rossi R. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma.. J Gerontol A Biol Sci Med Sci 2006 Oct;61(10):1030-8.
    doi: 10.1093/gerona/61.10.1030pubmed: 17077195google scholar: lookup
  39. Dröge W. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants.. Exp Gerontol 2002 Dec;37(12):1333-45.
    doi: 10.1016/S0531-5565(02)00175-4pubmed: 12559403google scholar: lookup
  40. Radi R, Bush KM, Cosgrove TP, Freeman BA. Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma.. Arch Biochem Biophys 1991 Apr;286(1):117-25.
    doi: 10.1016/0003-9861(91)90016-Cpubmed: 1897941google scholar: lookup
  41. Glover C.M., Miller L.M., Dybdal N.O., Lopez A, Duckett W.M., McFarlane D. Extrapituitary and pituitary pathological findings in horses with pituitary pars intermedia dysfunction: A retrospective study. J. Equine Vet. Sci. 2009;29:146–153.
  42. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004 Jul;10 Suppl:S18-25.
    doi: 10.1038/nrn1434pubmed: 15298006google scholar: lookup
  43. McFarlane D. Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease.. Ageing Res Rev 2007 May;6(1):54-63.
    doi: 10.1016/j.arr.2007.02.001pubmed: 17374512google scholar: lookup
  44. Yuan R.Y., Wu M.Y., Hu S.P. Antioxidant status in patients with Parkinson’s disease. Nutr. Res. 2000;20:647–652.
  45. de Laat MA, McGowan CM, Sillence MN, Pollitt CC. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses.. Equine Vet J 2010 Mar;42(2):129-35.
    doi: 10.2746/042516409X475779pubmed: 20156248google scholar: lookup
  46. Asplin KE, Sillence MN, Pollitt CC, McGowan CM. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.. Vet J 2007 Nov;174(3):530-5.
    doi: 10.1016/j.tvjl.2007.07.003pubmed: 17719811google scholar: lookup
  47. Johnson PJ, Messer NT, Ganjam VK. Cushing's syndromes, insulin resistance and endocrinopathic laminitis.. Equine Vet J 2004 Apr;36(3):194-8.
    doi: 10.2746/0425164044877279pubmed: 15147123google scholar: lookup
  48. Treiber K, Carter R, Gay L, Williams C, Geor R. Inflammatory and redox status of ponies with a history of pasture-associated laminitis.. Vet Immunol Immunopathol 2009 Jun 15;129(3-4):216-20.
    doi: 10.1016/j.vetimm.2008.11.004pubmed: 19108899google scholar: lookup
  49. Kenéz Á, Warnken T, Feige K, Huber K. Lower plasma trans-4-hydroxyproline and methionine sulfoxide levels are associated with insulin dysregulation in horses.. BMC Vet Res 2018 May 2;14(1):146.
    doi: 10.1186/s12917-018-1479-zpmc: PMC5930486pubmed: 29716602google scholar: lookup
  50. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance.. Nature 2006 Apr 13;440(7086):944-8.
    doi: 10.1038/nature04634pubmed: 16612386google scholar: lookup
  51. Becuwe P, Ennen M, Klotz R, Barbieux C, Grandemange S. Manganese superoxide dismutase in breast cancer: from molecular mechanisms of gene regulation to biological and clinical significance.. Free Radic Biol Med 2014 Dec;77:139-51.
  52. Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Maghzal GJ, Stocker R, Van Remmen H, Kraegen EW, Cooney GJ, Richardson AR, James DE. Insulin resistance is a cellular antioxidant defense mechanism.. Proc Natl Acad Sci U S A 2009 Oct 20;106(42):17787-92.
    doi: 10.1073/pnas.0902380106pmc: PMC2764908pubmed: 19805130google scholar: lookup

Citations

This article has been cited 0 times.